Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Following is an edited excerpt from one of the Rapid Responses generated by this article, which can be read in their entirety at http://bmj.com/cgi/eletters/326/7383/251 Editor
| The first 150 words of the full text of this article appear below. |
From BMJ USA 2003;April:202
Editor The proposal implied by Hall et al would lead to a rather rigid
prescribing protocol whereby all patients with scores above a threshold
(eg, 15%) would receive additional therapy, and others would not. In
addition, the overemphasis on risk scores might ignore other key risk
factors not represented by the Framingham risk equation, such as
ethnicity, family history, microalbuminuria, and triglyceride
concentration. The low baseline prevalence of diabetes in the
Framingham cohort leads to wide confidence intervals in the predicted
risk (±5-10%). Thus, in a diabetic man with average risk factors, the
upper 95% confidence interval crosses the 15% 10-year threshold from
age 40 onwards. It is quite plausible that individuals with risk scores
below a chosen cutoff
Bristol Royal Infirmary, Bristol, UK jamie.smith@virgin.net
What can you learn from this BMJ paper? Read Leanne Tite's Paper+